Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Low-Level Light Therapy for Hair Growth and Alopecia Treatment
Description
The talk reviews hair anatomy, the hair growth cycle, and common causes and types of alopecia, emphasizing that hair loss is both a cosmetic and functional problem with major genetic, hormonal, systemic, drug-related, and structural contributors. Current treatments include hair transplantation as the main gold standard for androgenic and other non-scarring alopecias, with minoxidil, finasteride, PRP, and excimer laser used as adjuncts. The main focus is low-level light therapy (LLLT), also called red light therapy, which was discovered serendipitously when irradiated mice grew hair. Although its exact mechanism is unknown, it is thought to influence hair cycling by promoting anagen reentry, prolonging anagen, increasing follicular proliferation, and preventing premature catagen. Clinical studies showed improved hair growth, density, thickness, and tensile strength in androgenic alopecia using 655 nm devices, laser combs, helmets, and other LED systems. The speaker also described animal studies where LLLT stimulated regrowth in heat-induced alopecia areata and sped recovery in chemotherapy-induced alopecia. Overall, LLLT appears safe and effective for stimulating hair growth, though optimal wavelengths and dosing parameters remain uncertain; reported side effects are usually mild, with transient telogen effluvium being the main concern.
View moreConclusions
- Low-level light therapy appears to be a safe and effective adjunct for stimulating hair growth, especially in androgenetic alopecia.
- The best-supported clinical evidence for LLLT is in non-scarring hair loss, particularly male and female pattern hair loss.
- LLLT may also help hair regrowth in alopecia areata and chemotherapy-induced alopecia, but the evidence is mostly from animal studies and is less definitive.
- The exact biological mechanism of LLLT remains unknown despite hypotheses about effects on the hair-growth cycle.
- Optimal treatment parameters such as wavelength, dose, and duration have not yet been established.
- Reported side effects are few and generally mild, with transient telogen effluvium being the most notable adverse event.
- Leavitt M, Abrahamse H, Hamblin MR et al. A randomized, double-blind, sham device-controlled, multicenter trial of a 655 nm laser device for treatment of male pattern hair loss. Clin Drug Investig. 2009;29(5):283-292.
- Lanzafame RJ, Blanche RR, Pruitt K, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in male androgenetic alopecia. Lasers Surg Med. 2013;45(10):487-495.#10.1002/lsm.22173
- Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: A 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013;39(8):1177-1183.#10.1111/dsu.12200
- Wikramanayake TC, Rodriguez R, Choudhary S, Mauro LM, Nouri K, Schachner LA, Jimenez JJ. Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata. Lasers Med Sci. 2012 Mar;27(2):431-6. PMID: 21739260.#10.1007/s10103-011-0953-7